Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


绿叶加速器免费永久加速-vp加速器官网

July 31, 2024 - Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results July 7, 2024 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2024 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

绿叶加速器免费永久加速-vp加速器官网

绿叶加速器免费永久加速-vp加速器官网

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

绿叶加速器免费永久加速-vp加速器官网

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
surf VP 下载 安卓  上外网加速器  快连vpn官方  嘿vp n下载官网  i站加速器  免费科学的上网工具